BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21477379)

  • 21. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
    Bhowmik T; Gomes A
    Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ClC-3 Chloride Channel Proteins Regulate the Cell Cycle by Up-regulating cyclin D1-CDK4/6 through Suppressing p21/p27 Expression in Nasopharyngeal Carcinoma Cells.
    Ye D; Luo H; Lai Z; Zou L; Zhu L; Mao J; Jacob T; Ye W; Wang L; Chen L
    Sci Rep; 2016 Jul; 6():30276. PubMed ID: 27451945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy.
    Peng W; Wu J; Feng J
    Clin Exp Med; 2017 Feb; 17(1):1-8. PubMed ID: 26475621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RN181 is a tumour suppressor in gastric cancer by regulation of the ERK/MAPK-cyclin D1/CDK4 pathway.
    Wang S; Wang X; Gao Y; Peng Y; Dong N; Xie Q; Zhang X; Wu Y; Li M; Li JL
    J Pathol; 2019 Jun; 248(2):204-216. PubMed ID: 30714150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CDK4 and miR-15a comprise an abnormal automodulatory feedback loop stimulating the pathogenesis and inducing chemotherapy resistance in nasopharyngeal carcinoma.
    Liu Z; Cheng C; Luo X; Xia Q; Zhang Y; Long X; Jiang Q; Fang W
    BMC Cancer; 2016 Mar; 16():238. PubMed ID: 26993269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for a CDK4-dependent checkpoint in a conditional model of cellular senescence.
    Brookes S; Gagrica S; Sanij E; Rowe J; Gregory FJ; Hara E; Peters G
    Cell Cycle; 2015; 14(8):1164-73. PubMed ID: 25695870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of p21(Waf1/Cip1) by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer.
    Yu SY; Liao CH; Chien MH; Tsai TY; Lin JK; Weng MS
    J Agric Food Chem; 2014 Mar; 62(9):2085-95. PubMed ID: 24533688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ara-c induces cell cycle G1/S arrest by inducing upregulation of the INK4 family gene or directly inhibiting the formation of the cell cycle-dependent complex CDK4/cyclin D1.
    Sun F; Li N; Tong X; Zeng J; He S; Gai T; Bai Y; Liu L; Lu K; Shen J; Han M; Lu C; Dai F
    Cell Cycle; 2019 Sep; 18(18):2293-2306. PubMed ID: 31322047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21.
    Vilgelm AE; Saleh N; Shattuck-Brandt R; Riemenschneider K; Slesur L; Chen SC; Johnson CA; Yang J; Blevins A; Yan C; Johnson DB; Al-Rohil RN; Halilovic E; Kauffmann RM; Kelley M; Ayers GD; Richmond A
    Sci Transl Med; 2019 Aug; 11(505):. PubMed ID: 31413145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential tumor suppressor NESG1 as an unfavorable prognosis factor in nasopharyngeal carcinoma.
    Liu Z; Luo W; Zhou Y; Zhen Y; Yang H; Yu X; Ye Y; Li X; Wang H; Jiang Q; Zhang Y; Yao K; Fang W
    PLoS One; 2011; 6(11):e27887. PubMed ID: 22140479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study on the Biological Function of Abemecilib in Inhibiting the Proliferation, Invasion and
Migration of Small Cell Lung Cancer with High c-Myc Expression].
    Guo J; Mu D; Yu W; Sun L; Zhang J; Ren X; Han Y
    Zhongguo Fei Ai Za Zhi; 2023 Feb; 26(2):105-112. PubMed ID: 36872049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.
    Jiang S; Zhao C; Yang X; Li X; Pan Q; Huang H; Wen X; Shan H; Li Q; Du Y; Zhao Y
    Int J Mol Med; 2016 Jul; 38(1):113-22. PubMed ID: 27247259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells.
    Kim YC; Chen C; Bolton EC
    PLoS One; 2015; 10(9):e0138286. PubMed ID: 26372468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitex rotundifolia Fruit Suppresses the Proliferation of Human Colorectal Cancer Cells through Down-regulation of Cyclin D1 and CDK4 via Proteasomal-Dependent Degradation and Transcriptional Inhibition.
    Song HM; Park GH; Park SB; Kim HS; Son HJ; Um Y; Jeong JB
    Am J Chin Med; 2018; 46(1):191-207. PubMed ID: 29298515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9.
    Dong QZ; Wang Y; Tang ZP; Fu L; Li QC; Wang ED; Wang EH
    Am J Pathol; 2013 Mar; 182(3):954-64. PubMed ID: 23306155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial creatine kinase 1 regulates the cell cycle in non-small cell lung cancer via activation of cyclin-dependent kinase 4.
    Yang M; Wang X; Ye Z; Liu T; Meng Y; Duan Y; Yuan X; Yue X; Deng W; Liu RY
    Respir Res; 2023 Apr; 24(1):111. PubMed ID: 37061730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circular RNA hsa_circ_0096157 contributes to cisplatin resistance by proliferation, cell cycle progression, and suppressing apoptosis of non-small-cell lung carcinoma cells.
    Lu H; Xie X; Wang K; Chen Q; Cai S; Liu D; Luo J; Kong J
    Mol Cell Biochem; 2020 Dec; 475(1-2):63-77. PubMed ID: 32767026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fascaplysin inhibit ovarian cancer cell proliferation and metastasis through inhibiting CDK4.
    Chen S; Guan X; Wang LL; Li B; Sang XB; Liu Y; Zhao Y
    Gene; 2017 Nov; 635():3-8. PubMed ID: 28888575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Artemisinin blocks prostate cancer growth and cell cycle progression by disrupting Sp1 interactions with the cyclin-dependent kinase-4 (CDK4) promoter and inhibiting CDK4 gene expression.
    Willoughby JA; Sundar SN; Cheung M; Tin AS; Modiano J; Firestone GL
    J Biol Chem; 2009 Jan; 284(4):2203-13. PubMed ID: 19017637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PRMT5 competitively binds to CDK4 to promote G1-S transition upon glucose induction in hepatocellular carcinoma.
    Yang H; Zhao X; Zhao L; Liu L; Li J; Jia W; Liu J; Huang G
    Oncotarget; 2016 Nov; 7(44):72131-72147. PubMed ID: 27708221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.